A detailed history of Jvl Associates LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jvl Associates LLC holds 1,101 shares of ABBV stock, worth $208,584. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,101
Holding current value
$208,584
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$163.84 - $199.33 $180,387 - $219,462
1,101 New
1,101 $217,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jvl Associates LLC Portfolio

Follow Jvl Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jvl Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jvl Associates LLC with notifications on news.